Literature DB >> 24953434

IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.

Vanessa Cousins1, Jed E Rose1, Edward D Levin2.   

Abstract

Tobacco smoking is characterized by repeated self-administration of nicotine by placing the cigarette in the mouth. The repeated hand-to-mouth self-administration is essentially a consummatory act. We recently developed a paradigm in which rats lick one of two spouts to trigger intravenous (IV) delivery of nicotine, which combines a consummatory act with rapid delivery of nicotine to model the act of tobacco smoking. We have found that rats will lick hundreds of times per nicotine infusion. In the current study, using the operant licking nicotine self-administration model with young adult Sprague-Dawley rats (0.03mg/kg/infusion of nicotine), we tested the effect of antagonists of H1 histamine receptors pyrilamine, serotonin (5HT) type 2 receptors ketanserin and N-methyl-d-aspartate (NMDA) glutamate receptors with d-cycloserine as well as an agonist of 5HT2c receptors lorcaserin, in dose ranges that we have found in previous studies to significantly reduce IV nicotine self-administration with the operant lever press operand. The H1 antagonist pyrilamine significantly reduced operant licking for nicotine self-administration. Pyrilamine caused significant reductions in the operant licking paradigm at lower doses (10 and 20mg/kg) than those we previously observed to affect responding in the operant lever press paradigm. In contrast, the 5HT2A and C antagonist ketanserin did not show an effect of reducing nicotine self-administration in the same dose range we had found in a previous study to significantly reduce operant lever press nicotine self-administration. The 5HT2C agonist lorcaserin significantly decreased nicotine self-administration in the licking paradigm at the same dose threshold as with lever press responding. The NMDA glutamate partial agonist d-cycloserine did not produce any change in nicotine self-administration with the licking operand, in contrast to its effect on the classic lever-pressing task. The rat model incorporating consummatory aspects of tobacco addiction can provide distinct and potentially more relevant information concerning possible new avenues of treatment to combat tobacco addiction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lorcaserin; Nicotine self-administration; Operant licking; Pyrilamine; d-cycloserine

Mesh:

Substances:

Year:  2014        PMID: 24953434      PMCID: PMC4135026          DOI: 10.1016/j.pnpbp.2014.06.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  19 in total

Review 1.  Cue dependency of nicotine self-administration and smoking.

Authors:  A R Caggiula; E C Donny; A R White; N Chaudhri; S Booth; M A Gharib; A Hoffman; K A Perkins; A F Sved
Journal:  Pharmacol Biochem Behav       Date:  2001-12       Impact factor: 3.533

2.  Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.

Authors:  Edward D Levin; Joshua E Johnson; Susan Slade; Corinne Wells; Marty Cauley; Ann Petro; Jed E Rose
Journal:  J Pharmacol Exp Ther       Date:  2011-06-02       Impact factor: 4.030

Review 3.  Importance of nonpharmacological factors in nicotine self-administration.

Authors:  Anthony R Caggiula; Eric C Donny; Nadia Chaudhri; Kenneth A Perkins; F Fay Evans-Martin; Alan F Sved
Journal:  Physiol Behav       Date:  2002-12

4.  A chamber for the instrumental control of licking behavior in the laboratory mouse.

Authors:  R L Sprott; F W Clark; R E Wimer
Journal:  J Exp Anal Behav       Date:  1970-11       Impact factor: 2.468

5.  Licking behavior of rats in relation to saccharin concentration and shifts in fixed-ratio reinforcement.

Authors:  S H Hulse
Journal:  J Comp Physiol Psychol       Date:  1967-12

6.  D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.

Authors:  Edward D Levin; Susan Slade; Corinne Wells; Ann Petro; Jed E Rose
Journal:  Pharmacol Biochem Behav       Date:  2010-12-28       Impact factor: 3.533

7.  Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Corinne Wells; Margaret Pruitt; Vanessa Cousins; Marty Cauley; Ann Petro; Dawn Hampton; Jed Rose
Journal:  Eur J Pharmacol       Date:  2010-10-15       Impact factor: 4.432

8.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

9.  Heroin self-administration: I. Incubation of goal-directed behavior in rats.

Authors:  Kara L Kuntz; Robert C Twining; Anne E Baldwin; Kent E Vrana; Patricia S Grigson
Journal:  Pharmacol Biochem Behav       Date:  2008-04-03       Impact factor: 3.533

10.  Reinforcement value of sucrose measured by progressive ratio operant licking in the rat.

Authors:  Anthony Sclafani; Karen Ackroff
Journal:  Physiol Behav       Date:  2003-09
View more
  7 in total

1.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

2.  Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.

Authors:  Laura Brandt; Jermaine D Jones; Suky Martinez; Jeanne M Manubay; Shanthi Mogali; Tatiana Ramey; Frances R Levin; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

3.  Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.

Authors:  Leigh V Panlilio; Maria E Secci; Charles W Schindler; Charles W Bradberry
Journal:  Psychopharmacology (Berl)       Date:  2017-09-04       Impact factor: 4.530

4.  Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.

Authors:  Scott A Briggs; Brandon J Hall; Corinne Wells; Susan Slade; Paul Jaskowski; Margaret Morrison; Amir H Rezvani; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2015-12-15       Impact factor: 3.533

Review 5.  The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.

Authors:  Gregory T Collins; Lisa R Gerak; Charles P France
Journal:  Neuropharmacology       Date:  2017-12-12       Impact factor: 5.250

6.  Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.

Authors:  Edward D Levin; Brandon J Hall; Autri Chattopadhyay; Susan Slade; Corinne Wells; Amir H Rezvani; Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2016-06-18       Impact factor: 4.530

7.  Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats.

Authors:  Magdalena Zaniewska; Agnieszka Nikiforuk; Urszula Głowacka; Sabina Brygider; Julita Wesołowska; Ewa Litwa; Marzena Maćkowiak
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.